KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Current Assets (2019 - 2025)

GoodRx Holdings' Current Assets history spans 7 years, with the latest figure at $565.5 million for Q3 2025.

  • For Q3 2025, Current Assets changed N/A year-over-year to $565.5 million; the TTM value through Sep 2025 reached $565.5 million, changed N/A, while the annual FY2024 figure was $659.3 million, 24.47% down from the prior year.
  • Current Assets for Q3 2025 was $565.5 million at GoodRx Holdings, up from $540.2 million in the prior quarter.
  • Across five years, Current Assets topped out at $1.1 billion in Q1 2021 and bottomed at $540.2 million in Q1 2025.
  • The 5-year median for Current Assets is $907.0 million (2023), against an average of $882.7 million.
  • The largest annual shift saw Current Assets rose 2.83% in 2023 before it decreased 24.47% in 2024.
  • A 5-year view of Current Assets shows it stood at $1.1 billion in 2021, then dropped by 15.53% to $919.7 million in 2022, then fell by 5.1% to $872.8 million in 2023, then fell by 24.47% to $659.3 million in 2024, then dropped by 14.22% to $565.5 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Current Assets are $565.5 million (Q3 2025), $540.2 million (Q1 2025), and $659.3 million (Q4 2024).